News
科思
Homepage
/
Development Path
/
2019

2019

  • Categories:Development Path
  • Author:
  • Origin:
  • Time of issue:2019-03-18 13:41
  • Views:

(Summary description)The company has obtained the approval for the clinical trial of "Fully Degradable Coronary Drug-Eluting Stent System" issued by the State Food and Drug Administration

2019

(Summary description)The company has obtained the approval for the clinical trial of "Fully Degradable Coronary Drug-Eluting Stent System" issued by the State Food and Drug Administration

  • Categories:Development Path
  • Author:
  • Origin:
  • Time of issue:2019-03-18 13:41
  • Views:
Information

The company has obtained the clinical trial approval for "fully degradable coronary drug-eluting stent system" issued by the State Food and Drug Administration

Previous: 2019
Next: 2018
Previous: 2019
Next: 2018
PeriSorb® fully degradable peripheral vascular stent completes the first FIM trial enrollment
2021 12-25

PeriSorb® fully degradable peripheral vascular stent completes the first FIM trial enrollment

This is the world's first 3D printed fully degradable peripheral stent implanted in the human body, marking that my country's 3D printing fully degradable peripheral stent with completely independent intellectual property rights has taken the lead in entering the clinical trial stage, and it also marks that my country's 3D printing technology has advanced to the world's leading level. A big step.
See more information
查看详情
Beijing adds 1,150 municipal-level "specialized, special and new" small and medium-sized enterprises
2021 12-03

Beijing adds 1,150 municipal-level "specialized, special and new" small and medium-sized enterprises

On December 1, the Beijing Economic and Information Bureau announced the list of the second to seventh batch of "specialized, special and new" small and medium-sized enterprises in Beijing in 2021. The list includes 1,150 small and medium-sized enterprises including Labtech, Digital Video, Geling Shentong, Moji Fengyun Technology, etc.
See more information
查看详情
Beijing Amet was recognized as a "specialized, special and new" enterprise
2021 12-02

Beijing Amet was recognized as a "specialized, special and new" enterprise

On December 1, 2021, the Beijing Municipal Bureau of Economy and Information issued an announcement on the seventh batch of "specialized, refined, and new" small and medium-sized enterprises in 2021. The announcement announced that Beijing Amet Medical Equipment Co., Ltd. was recognized as a "specialized, refined and new" enterprise. This event marks that Amet, as an innovative enterprise, has reached a high level in terms of scientific research strength, technical level and influence, and has been recognized by the competent government departments.
See more information
查看详情

Company Information

Beijing Advanced Medical Technologies,Ltd.Inc.

Contact Us

Address: Building 11, Zhongguancun Medical Equipment Park, No. 26, Yongwang West Road, Daxing District, Beijing

Tel：010-6297-7955           E-Mail：amt@ametcorp.com